Adient plc — FY2022 Form 10-K
Business context and reporting period: Adient is a global automotive seating supplier serving major vehicle manufacturers, with more than 200 manufacturing and assembly facilities in 31 countries. This annual report covers the fiscal year ended September 30, 2022; the filing text does not provide clear standalone fourth-quarter results.
Financial results and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Net sales | $14.121 billion | $13.680 billion |
| Gross profit / gross margin | $807 million / 5.7% | $826 million / 6.0% |
| Operating earnings before interest and taxes | $259 million | $1.726 billion |
| Net income (loss) attributable to Adient | $(120) million; $(1.27) per share | $1.108 billion; $11.76 per share |
| Cash provided by operating activities | $274 million | $260 million |
| Capital expenditures | $227 million | $260 million |
| Cash and cash equivalents at year-end | $947 million | $1.521 billion |
| Long-term debt, net of issuance costs | $2.564 billion | $3.512 billion |
Fiscal 2022 sales rose 3%, supported by higher volume, material-cost recoveries and consolidation of China operations acquired in the 2021 Yanfeng transaction. Gross profit declined, as currency effects, higher input costs and production interruptions outweighed those benefits. Net financing charges fell to $215 million from $311 million.
Operating cash flow increased modestly. The company reported $269 million of receivables funded through factoring/supply-chain finance programs, versus $132 million in FY2021; these proceeds are classified in operating cash flow. Investing activities provided $484 million, including divestiture-related proceeds. Financing activities used $1.273 billion, including $987 million of debt repayments and $153 million to acquire a noncontrolling interest in CQADNT.
Year-end working capital was $662 million, down from $1.575 billion. The company had $899 million of availability under its $1.25 billion asset-based revolving credit facility, net of letters of credit, with no amount drawn at year-end. Management said current financial resources should cover liquidity needs for at least the next 12 months.
Material changes and unusual items
- FY2021 results included approximately $1.214 billion of gains associated with China joint-venture transactions; this largely explains the sharp year-over-year decline in equity income and the swing from FY2021 profit to FY2022 loss.
- Adient acquired full ownership of CQADNT in China during FY2022. Consolidation increased reported Asia sales, while the change in business mix and ownership affected comparability and segment earnings.
- Adient repurchased its $600 million 9.00% notes and approximately $198 million of euro-denominated notes during FY2022, and repaid its European Investment Bank loan at maturity.
- Currency translation and other factors reduced goodwill to $2.057 billion from $2.212 billion. The company recorded no goodwill impairment in FY2022, although its annual assessment was a critical audit matter.
- Adient recorded a $32 million one-time gain from retrospective recovery of Brazil indirect tax credits, partly offset by restructuring, impairment and other nonrecurring charges.
Outlook, risks and contingencies
Management highlighted ongoing semiconductor and other supply disruptions, unplanned plant stoppages, China COVID-related lockdowns, the Russia-Ukraine conflict, higher energy, freight, commodity and labor costs, foreign-exchange pressure and rising interest rates. Customer recoveries may be delayed or may not fully offset increased costs. Management expects these challenges to continue into FY2023; the filing provides no clear consolidated FY2023 revenue or earnings guidance.
The FY2022 restructuring plan was $25 million, primarily for workforce reductions in EMEA and the Americas. Adient estimates approximately $20 million of annual operating-cost reductions upon completion, with about 20% expected to result in net savings; completion is expected substantially by FY2024. The company had approximately $2.6 billion of consolidated indebtedness and $3.952 billion of disclosed contractual cash obligations, including debt, interest, leases, purchases and pension contributions.
In November 2022, after fiscal year-end, the board authorized up to $600 million of share repurchases, with no expiration date. The company said repurchases would be measured and depend on market, business and working-capital conditions. Also after year-end, the ABL facility maturity was extended to November 2027, subject to springing-maturity provisions.
Other risks include automotive production cyclicality and customer concentration, pricing pressure, launch execution, joint-venture dependence, supplier and labor availability, pension assumptions, tax uncertainty, product liability and environmental matters. Management stated that pending legal matters were not expected to have a material adverse effect; environmental reserves were $6 million. The auditor and management reported effective internal control over financial reporting, and the auditor issued an unqualified opinion on the financial statements.
Key facts investors should verify
- How much of FY2022 operating cash flow reflects sustainable operations versus working-capital timing and receivables factoring.
- Underlying segment profitability, especially the deterioration in EMEA and Asia adjusted EBITDA, and the comparability effects of the CQADNT consolidation and prior-year China gains.
- Whether customer price recoveries and cost actions can offset inflation, freight, energy costs and production inefficiencies in FY2023.
- Debt maturities, refinancing conditions and covenant headroom, including the 2024 euro-note maturity and the ABL facility’s springing-maturity provisions.
- How the proposed share repurchases will be balanced against liquidity, debt reduction, capital spending and Irish-law distribution requirements.
- Goodwill valuation assumptions and tax-asset recoverability, including substantial tax-loss carryforwards subject to valuation allowances.